Craufurd D
Department of Clinical Genetics, St. Mary's Hospital, Manchester, U.K.
Prenat Diagn. 1996 Dec;16(13):1237-45. doi: 10.1002/(SICI)1097-0223(199612)16:13<1237::AID-PD98>3.0.CO;2-T.
Huntington's disease (HD) is a late-onset degenerative disorder of the central nervous system, caused by a dominantly inherited mutation in a gene on chromosome 4p. The identification of the trinucleotide repeat mutation responsible for this disorder has been an important step towards understanding the molecular pathology of HD, but in the meantime has also made it possible to offer predictive testing and prenatal diagnosis to individuals at high genetic risk. Predictive testing offers obvious benefits for those who receive a favourable result, but also runs the risk of significant psychological and social problems for the families involved. Uptake of testing to date has been limited. Prenatal testing where the pregnancy is at 25% risk carries the same disadvantages as adult predictive testing, because an unfavourable result would also establish that the at-risk parent is a gene carrier; prenatal exclusion testing offers an alternative method of detecting and terminating at-risk pregnancies without revealing the genetic status of the at-risk parent.
亨廷顿舞蹈症(HD)是一种中枢神经系统迟发性退行性疾病,由4号染色体短臂上一个基因的显性遗传突变引起。确定导致该疾病的三核苷酸重复突变是理解HD分子病理学的重要一步,但与此同时,这也使得对高遗传风险个体进行预测性检测和产前诊断成为可能。预测性检测对检测结果为阴性的人有明显益处,但对相关家庭来说也有产生重大心理和社会问题的风险。迄今为止,检测的接受度有限。当妊娠有25%的风险时进行产前检测与成人预测性检测有相同的弊端,因为检测结果为阳性也将确定风险方父母是基因携带者;产前排除检测提供了一种检测和终止有风险妊娠的替代方法,同时不暴露风险方父母的基因状态。